Tradestie Institutional Equity Comparison Engine

IOVA vs ANNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IOVA Overall Edge

IOVA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Iovance Biotherapeutics, Inc. Common Stock (IOVA) driven by superior Momentum & Technical, Options & Structure while ANNX counters with relative strength in Growth & Margin. Fundamentally, IOVA trades at N/M Forward P/E with -60.8% operating margin (+80.1% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, IOVA sits in BREAKDOWN (35th %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IOVA N/M vs ANNX N/M Fwd P/E
Growth & Margin Winner ANNX
Op Margin -60.8% vs 0.0% ยท YoY +80.1% vs +0.0%
Momentum & Technical Winner IOVA
1Y +204.9% vs +28.0% ยท 52W Pos 41% vs 18%
Options & Structure Winner IOVA
BREAKDOWN (35th %ile IV) vs BREAKDOWN (100th %ile IV)
IOVA NASDAQ
Iovance Biotherapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.53
-0.26% 1D
Market Cap $3.6B
1M Return -47.01%
1Y Return +204.86%
Forward P/E N/M
Unified AI Score
55.0 / 100 HOLD
Tech 53.0 Fund 61.0 Flow 70.0 Mom 60.0
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.47
-2.8% 1D
Market Cap $747.8M
1M Return -13.47%
1Y Return +28.04%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IOVA +204.86% ANNX +28.04% Spread: +176.82 pp (IOVA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IOVA TTM Op. Margin: -60.8% ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IOVA vs ANNX. Trailing 12-month operating profitability (IOVA -60.8% vs ANNX 0.0%) and valuation multiples (IOVA N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IOVA (5) vs ANNX (3)
Institutional Metric IOVA ANNX Criterion Row Winner
Market Capitalization Scale $3.6B $747.8M Larger Scale IOVA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +80.1% +0.0% Higher Growth IOVA
Operating Margin (TTM) Profitability -60.8% 0.0% Higher Margin ANNX
Net Profit Margin Profitability -58.2% 0.0% Higher Margin ANNX
Return on Equity (ROE) Capital Efficiency -29.1% -130.8% Higher ROE IOVA
52-Week Range Position Momentum 41% ($2โ€“$15) 18% ($3โ€“$7) Stronger Trend IOVA
Beta / 30D Volatility Risk Regime 1.58ฮฒ ยท 140% Vol 1.70ฮฒ ยท 63% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 55.0 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite IOVA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IOVA vs ANNX Buy Guide
IOVA BREAKDOWN
34d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 35th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live IOVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANNX BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IOVA nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.